62 related articles for article (PubMed ID: 28127819)
1. Comparing Papanicolaou test results obtained during pregnancy and post-partum.
Suzuki K; Furuhashi M; Kawamura T; Kubo M; Osato K; Yamawaki T
J Obstet Gynaecol Res; 2017 Apr; 43(4):705-709. PubMed ID: 28127819
[TBL] [Abstract][Full Text] [Related]
2. Follow-up of women with cervical cytological abnormalities showing atypical squamous cells of undetermined significance or low-grade squamous intraepithelial lesion: a nationwide cohort study.
Sundström K; Lu D; Elfström KM; Wang J; Andrae B; Dillner J; Sparén P
Am J Obstet Gynecol; 2017 Jan; 216(1):48.e1-48.e15. PubMed ID: 27457115
[TBL] [Abstract][Full Text] [Related]
3. Comparison of Papanicolaou test with visual detection tests in screening for cervical cancer and developing the optimal strategy for low resource settings.
Aggarwal P; Batra S; Gandhi G; Zutshi V
Int J Gynecol Cancer; 2010 Jul; 20(5):862-8. PubMed ID: 20606535
[TBL] [Abstract][Full Text] [Related]
4. Triage of the abnormal Papanicolaou smear in pregnancy.
Apgar BS; Zoschnick LB
Prim Care; 1998 Jun; 25(2):483-503. PubMed ID: 9628965
[TBL] [Abstract][Full Text] [Related]
5. Pap smears with glandular cell abnormalities: Are they detected by rapid prescreening?
Kanber Y; Charbonneau M; Auger M
Cancer Cytopathol; 2015 Dec; 123(12):739-44. PubMed ID: 26348845
[TBL] [Abstract][Full Text] [Related]
6. Antepartum and postpartum Papanicolaou smears. Are they both necessary?
Jazayeri A; Heffron JA; Harnetty P; Jazayeri M; Gould SF
J Reprod Med; 1999 Oct; 44(10):879-82. PubMed ID: 10554750
[TBL] [Abstract][Full Text] [Related]
7. Colposcopic management of abnormal cervical cytology in pregnancy.
LaPolla JP; O'Neill C; Wetrich D
J Reprod Med; 1988 Mar; 33(3):301-6. PubMed ID: 3361522
[TBL] [Abstract][Full Text] [Related]
8. Factors associated with reduced accuracy in Papanicolaou tests for patients with invasive cervical cancer.
Zhao L; Wentzensen N; Zhang RR; Dunn ST; Gold MA; Wang SS; Schiffman M; Walker JL; Zuna RE
Cancer Cytopathol; 2014 Sep; 122(9):694-701. PubMed ID: 24888458
[TBL] [Abstract][Full Text] [Related]
9. [Papanicolaou test in pregnancy].
Cheng X; Bian X; Lang J; Gai M; Liu X; Zhang J; Liu M
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2000 Apr; 22(2):174-6. PubMed ID: 12903522
[TBL] [Abstract][Full Text] [Related]
10. Guidelines for Papanicolaou test screening and follow-up.
Cox S; ;
J Midwifery Womens Health; 2012; 57(1):86-9. PubMed ID: 22251918
[No Abstract] [Full Text] [Related]
11. High-grade squamous intraepithelial lesions in pregnant and non-pregnant women.
Xavier-Júnior JC; Dufloth RM; do Vale DB; Tavares TA; Zeferino LC
Eur J Obstet Gynecol Reprod Biol; 2014 Apr; 175():103-6. PubMed ID: 24522115
[TBL] [Abstract][Full Text] [Related]
12. Improving the performance of reflex Human Papilloma Virus (HPV) testing in triaging women with atypical squamous cells of undetermined significance (ASCUS): A restrospective study in a tertiary hospital in United Arab Emirates (UAE).
Fakhreldin M; Elmasry K
Vaccine; 2016 Feb; 34(6):823-30. PubMed ID: 26747717
[TBL] [Abstract][Full Text] [Related]
13. Impact of the more restrictive definition of atypical squamous cells introduced by the 2001 Bethesda System on the sensitivity and specificity of the Papanicolaou test: a 5-year follow-up study of Papanicolaou tests originally interpreted as ASCUS, reclassified according to Bethesda 2001 criteria.
Thrall MJ; Pambuccian SE; Stelow EB; McKeon DM; Miller L; Savik K; Gulbahce HE
Cancer; 2008 Jun; 114(3):171-9. PubMed ID: 18454461
[TBL] [Abstract][Full Text] [Related]
14. The Korean guideline for cervical cancer screening.
Min KJ; Lee YJ; Suh M; Yoo CW; Lim MC; Choi J; Ki M; Kim YM; Kim JW; Kim JH; Park EW; Lee HY; Lim SC; Cho CH; Hong SR; Dang JY; Kim SY; Kim Y; Lee WC; Lee JK
J Gynecol Oncol; 2015 Jul; 26(3):232-9. PubMed ID: 26197860
[TBL] [Abstract][Full Text] [Related]
15. Expression of the MN antigen in cervical papanicolaou smears is an early diagnostic biomarker of cervical dysplasia.
Liao SY; Stanbridge EJ
Cancer Epidemiol Biomarkers Prev; 1996 Jul; 5(7):549-57. PubMed ID: 8827360
[TBL] [Abstract][Full Text] [Related]
16. The evaluation of cervical cancer screening by combining speculoscopy with Papanicolaou smear examination in Taiwan.
Chang JI; Ou CH; Wu KM; Chen CC; Cheng KC
Zhonghua Yi Xue Za Zhi (Taipei); 2002 Sep; 65(9):430-4. PubMed ID: 12433029
[TBL] [Abstract][Full Text] [Related]
17. HPV DNA testing with cytology triage in cervical cancer screening: Influence of revealing HPV infection status.
Richardson LA; El-Zein M; Ramanakumar AV; Ratnam S; Sangwa-Lugoma G; Longatto-Filho A; Cardoso MA; Coutlée F; Franco EL;
Cancer Cytopathol; 2015 Dec; 123(12):745-54. PubMed ID: 26230283
[TBL] [Abstract][Full Text] [Related]
18. Glandular Lesions of the Cervix in Clinical Practice: A Cytology, Histology, and Human Papillomavirus Correlation Study From 2 Institutions.
Miller RA; Mody DR; Tams KC; Thrall MJ
Arch Pathol Lab Med; 2015 Nov; 139(11):1431-6. PubMed ID: 25951104
[TBL] [Abstract][Full Text] [Related]
19. Is a liquid-based cytology more sensitive than a conventional Pap smear?
Sigurdsson K
Cytopathology; 2013 Aug; 24(4):254-63. PubMed ID: 23331613
[TBL] [Abstract][Full Text] [Related]
20. Daily peer review of abnormal cervical smears in the assessment of individual practice as an additional method of internal quality control.
Confortini M; Di Stefano C; Biggeri A; Bulgaresi P; Di Claudio G; Grisotto L; Maddau C; Matucci M; Petreschi C; Troni GM; Turco P; Foxi P
Cytopathology; 2016 Feb; 27(1):35-42. PubMed ID: 25123613
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
